Universal-Beteiligungs- und Servicegesellschaft’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Sell
244,606
-2,042
-0.8% -$90.5K 0.02% 533
2026
Q1
$7.33M Buy
246,648
+44,426
+22% +$1.33M 0.01% 723
2025
Q4
$7.73M Sell
202,222
-11,696
-5% -$380K 0.01% 702
2025
Q3
$5.11M Buy
213,918
+86,336
+68% +$1.62M 0.01% 861
2025
Q2
$1.89M Sell
127,582
-211,268
-62% -$3.5M ﹤0.01% 1268
2025
Q1
$6.07M Buy
338,850
+85,228
+34% +$1.73M 0.01% 736
2024
Q4
$4.42M Buy
+253,622
New +$4.49M 0.01% 739

Other funds holding TVTX

Universal-Beteiligungs- und Servicegesellschaft's TVTX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Travere Therapeutics (TVTX) stake by 0.83% in Q2 2026, selling an estimated $90.5K and leaving 244,606 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #533.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in TVTX in Q4 2024 and has held it in 7 quarters since. 169 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 244,606 shares of Travere Therapeutics worth $13.9M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,042 Travere Therapeutics shares in Q2 2026, an estimated $90.5K.
  • Travere Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #533 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Travere Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 169 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.